Study to Evaluate the Safety and Pharmacokinetics of SPI-1005
NCT01452607
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Hearing Loss
Cancer
Interventions
DRUG:
SPI-1005
DRUG:
Placebo
Sponsor
Sound Pharmaceuticals, Incorporated